HEALTHCARE NEWS THINGS TO KNOW BEFORE YOU BUY

Healthcare News Things To Know Before You Buy

Healthcare News Things To Know Before You Buy

Blog Article

New legislation aims to tame ‘Wild West’ in healthcare cybersecurity The proposed bill, launched last thirty day period by Sens. Ron Wyden and Mark Warner, is a superb stage forward, but hospitals might require much more money to boost their cybersecurity procedures, experts say.

Insurers will continue on vertically integrating to help keep much more revenue in-property, and federal scrutiny may even have an affect on pharmacy benefit managers as they unveil new programs they Monthly bill as far more transparent subsequent Congressional inquiries.

Healthcare technologies tendencies to view in 2024 Specialists explore their predictions for healthcare industry developments, together with expense and consolidation in digital wellbeing, adoption of artificial intelligence and bettering cybersecurity in healthcare in 2024.

 Leaders and executives will likely have a chance to community and be at the forefront of the evolving business in 2025 at some of the most important healthcare conferences.

Payer/service provider relationships As M&A intensifies and corporations embrace a lot more holistic and benefit-primarily based treatment versions, partnerships are getting to be a lot more intently intertwined.

four steps to minimize the specter of legacy health-related gadgets Older health care products with unsupported software package pose cybersecurity threats that regulators and field are battling to unravel. Here are four steps specialists say can help mitigate risks.

‘As rapidly as you can but no quicker than is Secure’: Hospitals, tech providers confront AI governance Regulators looking for to erect guardrails around AI are experiencing a Sisyphean activity, specialists claimed at HIMSS. How here would you oversee something that is consistently altering?

In 2024, there may be less hoopla and funds flowing in to the space as builders drinking water the seeds they planted previous yr, explained Vive’s Cheng.

The danger calculus can have currently adjusted for companies, since they encounter fines and damages from lawsuits after knowledge breaches, she noted.

FTC sues main pharmacy profit managers over insulin costs The company brought motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing cost of daily life-conserving insulin medications.

“In case you think about the cell phone like a platform, I feel nobody would've informed you in 2009 — once the iPhone was coming out — which the industries the apple iphone would disrupt most was likely to be the taxi marketplace with apps like Uber or the mapping market with such things as Google Maps,” he mentioned.

The fourth ingredient discusses options to market knowledge sharing, strengthen broadband infrastructure and provide assistance on cybersecurity. The earlier well being IT strategy, posted in Oct 2020, drove “sizeable development” throughout the government and personal sector to accelerate obtain, Trade and utilization of electronic health information and facts, in accordance with the company. The new plan aims to make on that do the job, aiming to modernize public wellness infrastructure following the COVID-19 pandemic, handle wellbeing disparities and tackle the swiftly evolving usage of AI in healthcare. Even though tech giants are promising AI tools that reduce vendors’ administrative jobs, some industry experts are involved there isn’t more than enough oversight in the immediately producing merchandise.

CMS retains accountable treatment companies harmless for ‘highly suspect’ Medicare billing Aberrant billing for urinary catheters past yr could have designed it more challenging for ACOs in Medicare to bring in shared savings. That’s no more the situation below a completely new closing rule.

FTC sues main pharmacy benefit supervisors over insulin selling prices The agency introduced action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the checklist cost of lifestyle-preserving insulin medicines.

Report this page